<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-E4OSMP2R</identifier><date>2021</date><creator>Ribnikar, Domen</creator><relation>documents/doc/E/URN_NBN_SI_doc-E4OSMP2R_001.pdf</relation><relation>documents/doc/E/URN_NBN_SI_doc-E4OSMP2R_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 27-29</format><identifier identifier_type="COBISSID_HOST">88074243</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-E4OSMP2R</identifier><language>slv</language><publisher publisher_location="Ljubljana">Združenje za radioterapijo in onkologijo SZD</publisher><source>Pregled in novosti v onkologiji (2021)</source><rights>BY-NC-ND</rights><subject language_type_id="slv">obsevanje</subject><subject language_type_id="slv">onkološko zdravljenje</subject><subject language_type_id="slv">radioterapija</subject><title>adjuvant chemotherapy in patients with early-stage HR+ HER-2 – negative breast cancer – an illusion</title><title>Adjuvantna kemoterapija pri zgodnjem HR+ HER2-raku dojk - utvara</title></Record>